Effect of Nitric Oxide Pathway Inhibition on the Evolution of Anaphylactic Shock in Animal Models: A Systematic Review
暂无分享,去创建一个
S. Alper | S. Al-Salam | A. Bellou | P. Mertes | E. Aburawi | R. H. Al-Rifai | Linda Östlundh | M. Alfalasi | S. Alzaabi | R. Al-Rifai
[1] P. Evora,et al. Indigo Carmine Hemodynamic Studies to Treat Vasoplegia Induced by Compound 48/80 in a Swine Model of Anaphylaxis , 2022, Brazilian journal of cardiovascular surgery.
[2] A. Muraro,et al. EAACI guidelines: Anaphylaxis (2021 update) , 2021, Allergy.
[3] J. Yusin,et al. Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and Beyond , 2021, International journal of molecular sciences.
[4] E. Mayo-Wilson,et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2021, BMJ.
[5] A. Muraro,et al. EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update) , 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[6] Heather B. Blunt,et al. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews , 2021, Systematic Reviews.
[7] P. Evora,et al. Effects of NO/cGMP inhibitors in a rat model of anaphylactoid shock , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[8] O. Collange,et al. Treatment with a platelet‐activating factor receptor antagonist improves hemodynamics and reduces epinephrine requirements, in a lethal rodent model of anaphylactic shock , 2019, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[9] M. Sahebazamani,et al. USE OF METHYLENE BLUE IN REFRACTORY ANAPHYLAXIS MAY PREVENT A CATASTROPHIC INTUBATION , 2019, Chest.
[10] S. Alper,et al. Cellular and Immunohistochemical Changes in Anaphylactic Shock Induced in the Ovalbumin-Sensitized Wistar Rat Model , 2019, Biomolecules.
[11] P. Furtado,et al. Methylene Blue to Treat Refractory Latex-Induced Anaphylactic Shock: A Case Report. , 2017, A&A practice.
[12] M. Tanida,et al. Renal response to anaphylaxis in anesthetized rats and isolated perfused rat kidneys: roles of nitric oxide , 2017, The Journal of Physiological Sciences.
[13] A. Oulhaj,et al. 4-Aminopyridine, A Blocker of Voltage-Dependent K+ Channels, Restores Blood Pressure and Improves Survival in the Wistar Rat Model of Anaphylactic Shock , 2016, Critical care medicine.
[14] P. Evora,et al. Methylene Blue to Treat Protamine-induced Anaphylaxis Reactions. An Experimental Study in Pigs , 2016, Brazilian journal of cardiovascular surgery.
[15] Joyce E. Yu,et al. The Epidemiology of Anaphylaxis , 2018, Clinical Reviews in Allergy & Immunology.
[16] M. Rovers,et al. SYRCLE’s risk of bias tool for animal studies , 2014, BMC Medical Research Methodology.
[17] A. Nemmar,et al. Glyburide, a K+ATP channel blocker, improves hypotension and survival in anaphylactic shock induced in Wistar rats sensitized to ovalbumin. , 2013, European journal of pharmacology.
[18] M. Tanida,et al. Nitric oxide and β2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice , 2013, Experimental lung research.
[19] O. Collange,et al. Methylene Blue and Epinephrine: A Synergetic Association for Anaphylactic Shock Treatment* , 2013, Critical care medicine.
[20] P. Vadas,et al. Methylene blue for the treatment of refractory anaphylaxis without hypotension. , 2013, The American journal of emergency medicine.
[21] I. Bernátová,et al. L-NAME in the cardiovascular system — nitric oxide synthase activator? , 2012, Pharmacological reports : PR.
[22] F. Finkelman,et al. Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice. , 2012, The American journal of pathology.
[23] P. Evora,et al. Methylene blue administration in the compound 48/80-induced anaphylactic shock: hemodynamic study in pigs. , 2011, Acta cirurgica brasileira.
[24] Takao Shimizu,et al. Mouse and human neutrophils induce anaphylaxis. , 2011, The Journal of clinical investigation.
[25] Calman Prussin,et al. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[26] Y. Kurata,et al. 7-NITROINDAZOLE, BUT NOT L-NAME OR AMINOGUANIDINE, ATTENUATES ANAPHYLACTIC HYPOTENSION IN CONSCIOUS RATS , 2009, Shock.
[27] S. Stawicki,et al. Methylene blue and vasoplegia: who, when, and how? , 2008, Mini reviews in medicinal chemistry.
[28] A. Cauwels. Nitric oxide in shock. , 2007, Kidney international.
[29] P. Evora,et al. Methylene blue for clinical anaphylaxis treatment: a case report. , 2007, Sao Paulo medical journal = Revista paulista de medicina.
[30] Wei Liu,et al. N(G)-nitro-L-arginine methyl ester, but not methylene blue, attenuates anaphylactic hypotension in anesthetized mice. , 2007, Journal of pharmacological sciences.
[31] Ben Janssen,et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. , 2006, The Journal of clinical investigation.
[32] John W. Clark,et al. Mathematical modeling of the nitric oxide/cGMP pathway in the vascular smooth muscle cell. , 2005, American journal of physiology. Heart and circulatory physiology.
[33] C. Piccinato,et al. THE USE OF METHYLENE BLUE IN THE TREATMENT OF ANAPHYLACTIC SHOCK INDUCED BY COMPOUND 48/80: EXPERIMENTAL STUDIES IN RABBITS , 2005, Shock.
[34] M. Yokoyama,et al. Role of nitric oxide in anaphylactic shock , 1995, Journal of Clinical Immunology.
[35] P. Evora,et al. [Methylene blue to treat anaphylaxis during anesthesia: case report.]. , 2004, Revista brasileira de anestesiologia.
[36] P. Evora,et al. Methylene blue: an effective treatment for contrast medium-induced anaphylaxis. , 2003, Medical science monitor : international medical journal of experimental and clinical research.
[37] Z. Vered,et al. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. , 2003, European heart journal.
[38] D. Longrois,et al. Constitutive Nitric Oxide Synthase Inhibition Combined with Histamine and Serotonin Receptor Blockade Improves the Initial Ovalbumin-Induced Arterial Hypotension but Decreases the Survival Time in Brown Norway Rats Anaphylactic Shock , 2003, Shock.
[39] E. Masini,et al. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway , 2002, British journal of pharmacology.
[40] H. Bruining,et al. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock. , 1998, Chest.
[41] C. Nathan,et al. Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .
[42] P. Evora,et al. Methylene blue in anaphylactic shock. , 1997, Annals of emergency medicine.
[43] Hong-Gang Wang,et al. Participation of nitric oxide in the sympathetic response to anaphylactic hypotension in anesthetized dogs , 1996, Neuroscience Letters.
[44] R. F. Davis,et al. Indigo carmine inhibits endothelium-dependent and -independent vasodilation. , 1996, Hypertension.
[45] R. Shimizu,et al. NITRIC OXIDE SYNTHASE INHIBITION IS DETRIMENTAL TO CARDIAC FUNCTION AND PROMOTES BRONCHOSPASM IN ANAPHYLAXIS IN RABBITS , 1995, Shock.
[46] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[47] R. Shimizu,et al. An inhibitor of nitric oxide synthase, N omega-nitro-L-arginine-methyl ester, attenuates hypotension but does not improve cardiac depression in anaphylaxis in dogs. , 1995, Shock.
[48] H. Oku,et al. Participation of nitric oxide in mouse anaphylactic hypotension. , 1994, European journal of pharmacology.
[49] H. Saito,et al. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? , 1992, Circulation research.
[50] P. Vallance,et al. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock , 1991, The Lancet.
[51] S. Amir,et al. An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. , 1991, European journal of pharmacology.